1. Pink Sheet
  2. >>Market Access

Latest WHO Essential Medicines List: New Drugs And A New Way Of Tackling Antibiotic Resistance

 
• By Ian Schofield

New drugs for leukemia, hepatitis C, HIV and tuberculosis have made it onto the 20th edition of the World Health Organization’s Essential Medicines List, which also features a new categorization system for antibiotics in a fresh effort to curb the rise of antibacterial resistance.

Rural village
The WHO's Essential Medicines List helps developing countries improve access to medicines

The World Health Organization has published the latest edition of its Essential Medicines List, adding 30 medicines for adults and 25 for children, as well as new uses for already listed products, bringing to 433 the number of drugs that the WHO says address important public health needs at global level.

A number of newer innovative products have been placed on the list, including dasatinib and nilotinib for leukemia, sofosbuvir/velpatasvir for hepatitis C, dolutegravir for HIV

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 
• By Sue Sutter and Derrick Gingery

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.